US equities
|
MU
$1,029.00
▼-0.66%
NVDA
$229.28
▼-0.52%
SPCX
$162.57
▲+1.25%
TSLA
$382.70
▲+2.05%
AAPL
$336.64
▼-1.11%
MSFT
$535.07
▲+2.38%
AMZN
$262.43
▲+3.29%
META
$718.67
▼-0.31%
MU
$1,029.00
▼-0.66%
NVDA
$229.28
▼-0.52%
SPCX
$162.57
▲+1.25%
TSLA
$382.70
▲+2.05%
AAPL
$336.64
▼-1.11%
MSFT
$535.07
▲+2.38%
AMZN
$262.43
▲+3.29%
META
$718.67
▼-0.31%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Beyond Air, Inc. - Common Stock
(NQ:
XAIR
)
2.250
-0.060 (-2.60%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Beyond Air, Inc. - Common Stock
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
March 13, 2026
From
Virtual Investor Conferences
Via
GlobeNewswire
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
March 10, 2026
Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership
January 13, 2026
From
XTL Biopharmaceuticals Ltd.
Via
GlobeNewswire
Beyond Air Inc. (NASDAQ: XAIR) Making Surprising Moves in Tuesday Session
August 08, 2023
Via
Investor Brand Network
InvestorNewsBreaks – Beyond Air Inc. (NASDAQ: XAIR) Reports on $16M Registered Direct Offering with Health-Care Focused Investors
March 27, 2024
Via
Investor Brand Network
Beyond Air Inc. (NASDAQ: XAIR) Near the Top of Equities by Percentage Gain on 10/20
October 20, 2023
Via
Investor Brand Network
3 Healthcare Stocks Insiders Are Buying
April 13, 2023
The healthcare industry is looking forward to double-digit growth, and these stocks the insiders are buying have analyst support too.
Via
MarketBeat